본문 바로가기
KERD
논문KCI 등재

Pub Med에서 검색된 난소 과자극 증후군에대한 최신 연구 고찰

Systemic Review :The Study on Ovarian hyperstimulation syndrome(OHSS)

손영주|정민영
대한한방부인과학회 (The Society Of Oriental Obstetrics & Gynecology)|2005.02|대한한방부인과학회지 (The Journal of Oriental Obstetrics ＆ Gynecology)|제18권 제1호|pp. 192-206

0

조회

0

다운로드

1

인용

0

참고문헌

주제분류한의학

초록

Abstract

Objective : To know about ovarian hyperstimulation syndrome pathophysiology, risk factors and clinical features and to research the trend of the study related to OHSS. Methods : We referred a PubMed site by using searching word of "ovarian hyperstimulation syndrome"(Limits: 1 Year, only items with abstracts, Human). Results : 28 journals with 49 papers were searched. Conclusion 1. The study of OHSS subjects on pathophysiology, prevention and medical treatment. 2.As OHSS is an exaggerated response to ovulation induction therapy, it's emphasized that aspect of prevention OHSS. 3.Preventing OHSS are the following. The first is to give a GnRH agonist or antagonist in substitute for hCG. The second is to screen out prevalence of thrombophilia. The third is to monitor E2 levels. The forth is to aspirate of Mediculous follicle. The fifth is cryopreservation of all embryos. The sixth is that administration of albumin for treatment of OHSS. But, it's not useful to administration of albumin for prevention of OHSS. 4. There's no therapy of OHSS. But, there's only symptomatic treatment of OHSS.

참고문헌 (39)

  1. "Ovarian hyperstimulation syndrome", 80(5), pp.1309~1314 (2003)
  2. "prevention and management of ovarian hyperstimulation syndrome", 102(10), pp.767~72 (1995)
  3. "A fetal case of Ovarian hyperstimulation syndrome with cerebral infaction", 27, pp.344~6 (1995)
  4. "Risk factors and Prognostic variables in the Ovarian hyperstimulation syndrome", 159, pp.210~5 (1988)
  5. "배란 유도시 발생한 중증 난소 과자극 증후군에 대한 임상적 고찰", 37(10), pp.2019~2027 (1994)
  6. "The effect of 'coasting' on follicular fluid concentrations of Vascular endothalial growth factor in women at risk of developing ovarian hyperstimulation syndrome", 19(3), pp.522~8 (2004)
  7. "New insights into the pathophysiology of ovarian hyperstimulation syndrome What makes the difference between spotaneous and iatrogenic syndrome", 19(3), pp.486~9 (2004)
  8. "A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome", 89(4), pp.1255~8 (2004)
  9. "Contemporary pharmacological manipulation in assisted reproduction", 64(3), pp.297~322 (2004)
  10. "Luteolysis induced by gonadotropin-releasing hormon agonist is the key to prevention of Ovarian hyperstimulation syndrome", 81(1), pp.1~5 (2004)
  11. "Prevalence of Thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening", 81(4), pp.989~995 (2004)
  12. "Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome", 81(2), pp.332~6 (2004)
  13. "Interlukin-18 levels correlate with severe ovarian hyperstimulation syndrome", 82(2), pp.415~20 (2004)
  14. "Outcome of follicular aspiration of selection phase in patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation", 39(8), pp.522~5 (2004)
  15. "Cumulative first live birth after elective cryopreservation of all embryos due to ovarian hyperresponsiveness", 81(2), pp.309~314 (2004)
  16. "Intravenenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients", 18(11), pp.2283~8 (2003)
  17. "Thromboembolism after ovarian stimulation successful management of a woman with superior sagittal sinus thrombosis after IVF and embryo transfer", 18(11), pp.2375~81 (2003)
  18. "Continous abdominal paracentesis for management of late type severe ovarian hyperstimulation syndrome", 67(4), pp.197~9 (2004)
  19. "Unilateral pleural effusion as the main presentation of", 81(4), pp.1127~1129 (2004)
  20. "Clinical aspects of ovarian hyperstimulation syndrome", 85, pp.13~20 (1999)
  21. "Role of vascular endothelial growth factor in ovarian physiology and pathology", 74, pp.429~38 (2000)
  22. "Angiogenesis in the human female reproductive tract", 50, pp.688~97 (1995)
  23. "Use of gonadotropin releasing hormone agonist to trigger follicular maturation for in vitro fertilation", 71, pp.918~22 (1990)
  24. "tominimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles", 71, pp.294~301 (1997)
  25. "Prospective randomized study of human chorionic gonadotropin versus intramuscular progesterone for invitro fertilization", 14, pp.1457~60 (1999)
  26. "The management of predicted OHSS involving gonadotropin-releasing hormone analogte with elective cryopreservaton of all preembryos", 53, pp.1087~90 (1990)
  27. "Elective cryopreservationof allpronucleate embryos in woman at risk of ovarian hyperstimulation syndrome", gia(reli l), pp.933~7 (1990)
  28. "Moden-Vrtovec H", 13, pp.282~6 (1996)
  29. "Plasma estradiol is superior to ultrasound and urinary estradiol glucuronide as apredictor of ovarian hyperstimulation during induction of ovulation with menotrpins", 40, pp.31~ (1983)
  30. "내경 정맥 혈전증을 동반한 중증 난소과자극 증후군 1예", 47(6), pp.1251~1254 (2004)
  31. "다량의 흉수를 동반한 난소 과자극 증후군 1례", 44(3), pp.689~ (1997)
  32. "부인과 내분비학", pp.387~434 (1996), 고려의학
  33. "난소에서의 난포기 발육과 관련되는 성스테로이드 대사의 역할", 12, pp.1~ (1985)
  34. "Human menopauseal gonadotropins for anovaulation and sterlity"
  35. "a new approach to ovarian hyperstimulation"
  36. "Human albumin solutions", 300, pp.35~7 (1990)
  37. "Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program"
  38. "The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome", pp.10~15
  39. "중증 난소 과자극 증후군의 고 위험군에서 예방적 Albumin 정맥주사요법의 효과", 39(2), pp.355~364 (1996)

관련 논문AI추천

체외수정시술을 받는 다낭성난소증후군 환자들에서GnRH Antagonist를 이용한 과배란유도의 효용성강병문, 김성훈, 김정훈, 나희영, 손영수, 이영진, 이향아, 채희동, 최정원, 홍석호대한산부인과학회 · Obstetrics & Gynecology Science2005 · 제48권 제3호PUBMED 검색을 통한 반복유산의 최신 연구에 관한 고찰문현준, 임은미대한한방부인과학회 · 대한한방부인과학회지2004 · 제17권 제2호난소과자극증후군의 치료에 관한 한의 임상 연구 고찰구수정, 이진무, 이창훈, 장준복, 황덕상대한한방부인과학회 · 대한한방부인과학회지2020 · 제33권 제3호과배란유도에 대한 난소반응 예측인자로서 기저 및탈감작후 황체화호르몬 농도김기형, 서동수, 이국원, 이규섭, 정은주, 조무성대한산부인과학회 · Obstetrics & Gynecology Science2004 · 제47권 제3호입원을 요하는 중증 난소과자극 증후군 (Severe ovarian hyperstimulation syndrome) 환자에서 난자 채취시의예방적 albumin 투여가 임상 경과에 미치는 영향허걸, 강인수, 궁미경, 김은정, 김진영, 송인옥, 송지홍, 양광문, 유근재, 임하정, 전종영대한산부인과학회 · Obstetrics & Gynecology Science2002 · 제45권 제9호체외수정시술시 정상 난소 반응 예측 환자에서 Gonadotropin-releasing hormone antagonist와agonist의 효용성에 관한 연구김석현, 김선미대한산부인과학회 · Obstetrics & Gynecology Science2004 · 제47권 제5호

이 간행물의 다른 논문 (19건)

瑞金散의 抗血栓作用에 對한 實驗的 硏究유동열, 이정은, 이보라, 김의일pp. 1-14宮頸1號煎이 子宮頸部癌細胞(HeLa Cell)에 미치는 影響최창민, 강영금, 유심근, 조한백pp. 15-28馬齒？이 子宮頸部癌細胞(HeLa Cell)에 미치는 影響김양호, 유심근, 강복환, 엄주오pp. 29-44SKBR3 유방암세포주에 대한 귀전우 메탄올 추출물의 성장억제 및 항산화효과박영은, 한지영, 김동일, 이태균pp. 45-54紫河車가 칼슘재흡수, cyclooxygenase의 발현, PGE2 생합성에 미치는 영향이태균, 정연호, 김나영, 김동일pp. 55-63
원문 보기